| |
 |
|
Class Information
Number: 514/29
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > O-glycoside > Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring > The hetero ring has 8 or more ring carbons > The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)
Description: Subject matter wherein the nonsaccharide hetero ring has exactly 13 carbon atoms, e.g., erythromycin, etc.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6379882 |
Method for selecting compounds for treating ischemia-related cellular damage |
Apr. 30, 2002 |
| 6369035 |
3,6-hemiketals from the class of 9A-azalides |
Apr. 9, 2002 |
| 6365574 |
Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
Apr. 2, 2002 |
| 6355620 |
C-2 modified erythromycin derivatives |
Mar. 12, 2002 |
| 6339063 |
9a-azalides as veterinary antimicrobial agents |
Jan. 15, 2002 |
| 6329345 |
13-membered azalides and their use as antibiotic agents |
Dec. 11, 2001 |
| 6319904 |
Formulation comprising antibacterial substance and antiulcer substance |
Nov. 20, 2001 |
| 6313101 |
Derivatives of erythromycin, their preparation process and their use as medicaments |
Nov. 6, 2001 |
| 6306613 |
Modulators of leaderless protein export and methods for identifying and using the same |
Oct. 23, 2001 |
| 6300316 |
C-4 substituted macrolide antibiotics |
Oct. 9, 2001 |
| 6281199 |
Method of treatment of heart disease caused by Chlamydia pneumoniae |
Aug. 28, 2001 |
| 6281197 |
Cardiac glycosides and their aglycone derivatives treat complications of diabetes |
Aug. 28, 2001 |
| 6277829 |
Process for preparing of aqueous formulation for opthalmic use |
Aug. 21, 2001 |
| 6277836 |
Methods and compositions for treating inflammatory bowel disease |
Aug. 21, 2001 |
| 6274560 |
Cell-free synthesis of polyketides |
Aug. 14, 2001 |
| 6271255 |
Erythromycins and process for their preparation |
Aug. 7, 2001 |
| 6262030 |
Erythromycin derivatives |
Jul. 17, 2001 |
| 6258785 |
Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribohexopyrano syloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1 |
Jul. 10, 2001 |
| 6248719 |
Tricyclic 3-keto derivatives of 6-O-methylerthromycin |
Jun. 19, 2001 |
| 6248718 |
Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity |
Jun. 19, 2001 |
| 6239113 |
Topical treatment or prevention of ocular infections |
May. 29, 2001 |
| 6239112 |
Water miscible macrolide solutions |
May. 29, 2001 |
| 6218368 |
Antibiotic treatment of age-related macular degeneration |
Apr. 17, 2001 |
| 6194387 |
6-O-aklyl erythromycin B oxime |
Feb. 27, 2001 |
| 6191118 |
Erythromycin A derivatives |
Feb. 20, 2001 |
| 6187768 |
Kit for flushing medical devices and method of preparation |
Feb. 13, 2001 |
| 6174865 |
Method of treating hypertriglyceridemia with an erythromycin compound |
Jan. 16, 2001 |
| 6172069 |
Method for preventing or reducing photosensitivity and or photoxicity reaction to medications |
Jan. 9, 2001 |
| 6165986 |
Erythromycin a derivatives |
Dec. 26, 2000 |
| 6165985 |
11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
Dec. 26, 2000 |
| 6162792 |
Use of spiramycin for treating gastrointestinal disorders caused by H. pylori |
Dec. 19, 2000 |
| 6162793 |
Erythromycin derivatives, method for preparing same and use thereof as drugs |
Dec. 19, 2000 |
| 6162794 |
Erythromycin derivatives |
Dec. 19, 2000 |
| 6159945 |
9-amino-3-keto erythromycin derivatives |
Dec. 12, 2000 |
| 6140479 |
Erythromycin a derivatives |
Oct. 31, 2000 |
| 6124269 |
2-Halo-6-O-substituted ketolide derivatives |
Sep. 26, 2000 |
| 6107283 |
Cardiac glycosides inhibit proliferation of cells bearing FGF receptors |
Aug. 22, 2000 |
| 6100240 |
Macrolide derivatives |
Aug. 8, 2000 |
| 6100239 |
13-membered ring macrolide compound, medicine containing the same, and process for producing the same |
Aug. 8, 2000 |
| 6096714 |
Erythromycin derivatives, method for preparing same, and use thereof as drugs |
Aug. 1, 2000 |
| 6083706 |
Inhibitors of leaderless protein export |
Jul. 4, 2000 |
| 6075011 |
6-O-substituted erythromycin compounds and method for making same |
Jun. 13, 2000 |
| 6071886 |
.beta.,.beta.-distributed derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A |
Jun. 6, 2000 |
| 6071885 |
Treatment of FGF-mediated conditions by administration of a cardiac glycoside or aglycone derivative thereof |
Jun. 6, 2000 |
| 6063561 |
Polyketide derivatives and recombinant methods for making same |
May. 16, 2000 |
| 6060234 |
Polyketide derivatives and recombinant methods for making same |
May. 9, 2000 |
| 6054435 |
6-O-substituted macrolides having antibacterial activity |
Apr. 25, 2000 |
| 6054434 |
8a-azalides as veterinary antimicrobal agents |
Apr. 25, 2000 |
| 6046171 |
6,11-bridged erythromycin derivatives |
Apr. 4, 2000 |
| 6043225 |
Diagnosis and treatment of arterial chlamydial granuloma |
Mar. 28, 2000 |
|
|
|
